SCHEMBL20249698

SCHEMBL20249698

Cc1c2c(-c3ccc(F)cc3)nc3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)ccc3c2c(C)c2c(-c3ccc(F)cc3)nc3ccccc3c12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 4/20 0.44
DHODH Q02127 4/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
ATM Q13315 1/20 0.43
ADORA2A P29274 1/20 0.43
AURKA O14965 1/20 0.42
AURKB Q96GD4 1/20 0.42
MAPT P10636 5/20 0.41
LMNA P02545 2/20 0.41
WHR1 P49842 1/20 0.40
KDM1A O60341 1/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
PPARG P37231 1/20 0.40
NCOA2 Q15596 1/20 0.40
NCOA1 Q15788 1/20 0.40
NCOA3 Q9Y6Q9 1/20 0.40
ABCB1 P08183 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20249701 0.96 ABCG2 (0.41) ABCG2DHODHMEN1KMT2AATM
SCHEMBL20249673 0.96 DHODH (0.46) ABCG2DHODHMEN1KMT2AATM
SCHEMBL20249646 0.94 MEN1 (0.48) DHODHMEN1KMT2AATMWHR1
SCHEMBL20249676 0.93 CYP19A1 (0.43) ABCG2DHODHMEN1KMT2AADORA2A
SCHEMBL20245084 0.91 DHODH (0.43) ABCG2DHODHMEN1KMT2AADORA2A
SCHEMBL20245165 0.90 MEN1 (0.45) ABCG2DHODHMEN1KMT2AATM
SCHEMBL20249691 0.90 DHODH (0.47) DHODHMEN1KMT2AATMWHR1
SCHEMBL20249631 0.90 CYP19A1 (0.40) ABCG2DHODHMEN1KMT2AADORA2A
SCHEMBL20249700 0.88 MEN1 (0.44) ABCG2DHODHMEN1KMT2AATM
SCHEMBL20249706 0.87 ATM (0.54) ABCG2DHODHMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-06-23 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2018-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180166635-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 ABCG2 4586/4885DHODH 1907/4885MEN1 394/4885
US-10693083-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 ABCG2 4586/4885DHODH 1907/4885MEN1 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.